Pharmacists’ profit margins will be adjusted in accordance with price increases dependent on currency exchange rate updates. The Ministry of Health’s statement regarding the regulation published in the Official Gazette yesterday noted that drug prices are updated annually based on the periodical changes in the euro rate and in accordance with the “Regulation on Pricing of Human Medicinal Products.” It was mentioned in the statement that this update is calculated based on a certain percentage of the average euro value of the previous year, and that the current value is determined within the framework of budget discipline, covering not only human medicinal products but also imported drugs. The statement also conveyed that due to the lack of annual updates in the current regulations, pharmacy profit margins remain constant, resulting in many drugs being sold below the highest margin due to low profitability rates. It was explained that pharmacists’ profitability ranges are applied as 28% for first-tier drugs (up to 328 liras), 18% for second-tier drugs (328-657 liras range), and 13% for third-tier drugs (above 657 liras). The statement mentioned that the regulation published in the Official Gazette yesterday will provide a significant advantage for pharmacists, stating that “Pharmacists’ profitability ranges will now be reassessed in each currency update period. Therefore, the basic drug price ranges for pharmacists’ profits will also increase in the same proportion as the updates in drug prices. Pharmacists will benefit equally from drug price increases, preventing income losses.”